Terms: = Endocrine gland cancer AND HNRNPA2B1, ENSG00000122566, SNRPB1, RNPA2, HNRPB1, HNRPA2, HNRNPB1, HNRNPA2, 3181 AND Prognosis
6 results:
1. Identification of miR-30c-5p as a tumor suppressor by targeting the m
Wu Q; Li G; Gong L; Cai J; Chen L; Xu X; Liu X; Zhao J; Zeng Y; Gao R; Yu L; Wang Z
Cancer Med; 2023 Feb; 12(4):5055-5070. PubMed ID: 36259156
[TBL] [Abstract] [Full Text] [Related]
2. m6A RNA methylation regulators were associated with the malignancy and prognosis of ovarian cancer.
Zhang C; Liu J; Guo H; Hong D; Ji J; Zhang Q; Guan Q; Ren Q
Bioengineered; 2021 Dec; 12(1):3159-3176. PubMed ID: 34187307
[TBL] [Abstract] [Full Text] [Related]
3. Vitamin D receptor upregulates lncRNA TOPORS-AS1 which inhibits the Wnt/β-catenin pathway and associates with favorable prognosis of ovarian cancer.
Fu Y; Katsaros D; Biglia N; Wang Z; Pagano I; Tius M; Tiirikainen M; Rosser C; Yang H; Yu H
Sci Rep; 2021 Apr; 11(1):7484. PubMed ID: 33820921
[TBL] [Abstract] [Full Text] [Related]
4. Analysis of m6A-Related Signatures in the Tumor Immune Microenvironment and Identification of Clinical Prognostic Regulators in Adrenocortical Carcinoma.
Jin Y; Wang Z; He D; Zhu Y; Hu X; Gong L; Xiao M; Chen X; Cheng Y; Cao K
Front Immunol; 2021; 12():637933. PubMed ID: 33746977
[TBL] [Abstract] [Full Text] [Related]
5. Linc01232 promotes the metastasis of pancreatic cancer by suppressing the ubiquitin-mediated degradation of hnrnpa2b1 and activating the A-Raf-induced MAPK/ERK signaling pathway.
Meng LD; Shi GD; Ge WL; Huang XM; Chen Q; Yuan H; Wu PF; Lu YC; Shen P; Zhang YH; Cao SJ; Miao Y; Tu M; Jiang KR
Cancer Lett; 2020 Dec; 494():107-120. PubMed ID: 32814086
[TBL] [Abstract] [Full Text] [Related]
6. Loss of hnrnpa2b1 inhibits malignant capability and promotes apoptosis via down-regulating Lin28B expression in ovarian cancer.
Yang Y; Wei Q; Tang Y; Yuanyuan Wang ; Luo Q; Zhao H; He M; Wang H; Zeng Q; Lu W; Xu J; Liu T; Yi P
Cancer Lett; 2020 Apr; 475():43-52. PubMed ID: 32006618
[TBL] [Abstract] [Full Text] [Related]
